3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
36
Leukemia
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Gastrointestinal Stromal Tumors
13
Leukemia, Myeloid, Chronic-Phase
12
Leukemia, Myeloid
6
Brain Neoplasms
6
Prostatic Neoplasms
5
Philadelphia Chromosome
5
Blast Crisis
5
Sarcoma
4
Recurrence
4
Glioblastoma
4
Carcinoma, Non-Small-Cell Lung
4
Bone Marrow Diseases
4
Ovarian Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Hematologic Diseases
3
Bronchiolitis Obliterans Syndrome
3
Breast Neoplasms
3
Stomach Neoplasms
2
Polycythemia Vera
2
Neurofibromatoses
2
Neoplasms by Histologic Type
2
Neoplasms
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Meningioma
2
Interventions
Radiotherapy
2
Pyridoxine
2
Etoposide
2
Cytarabine
2
Cyclophosphamide
2
sodium thiosulfate
1
pegfilgrastim
1
pegaspargase
1
etoposide phosphate
1
Vincristine
1
Triptorelin Pamoate
1
Rituximab
1
Prednisolone
1
Methylprednisolone
1
Methotrexate
1
Mercaptopurine
1
Leucovorin
1
Hydrocortisone
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Doxorubicin
1
Dexrazoxane
1
Dexamethasone
1
Celecoxib
1
Carboplatin
1
Capecitabine
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Drug-Related Side Effects and Adverse Reactions
×
Imatinib Mesylate
×
Clear all
No trials found.